We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.89T
1-Year Est. Return 35.08%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
+21.2%
1 Year Est. Return
+35.08%
3 Year Est. Return
+108.59%
5 Year Est. Return
+118.76%
10 Year Est. Return
+494.78%
AUM
$1.89T
AUM Growth
+$231B
Cap. Flow
+$19.1B
Cap. Flow %
1.01%
Top 10 Hldgs %
21.09%
Holding
8,715
New
423
Increased
3,809
Reduced
3,216
Closed
305

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$2.77B
2
MCK icon
McKesson
MCK
+$2.38B
3
SPCX
SpaceX
SPCX
+$2.3B
4
HONA
Honeywell Aerospace
HONA
+$2.05B
5
AMZN icon
Amazon
AMZN
+$1.37B

Sector Composition

Rank Sector Weight
1 Miscellaneous 26.02%
2 Technology 24.63%
3 Financials 9.78%
4 Healthcare 7.32%
5 Industrials 7.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BIO.B icon
5776
Bio-Rad Laboratories Class B
BIO.B
$214K ﹤0.01%
712
SEAT icon
5777
Vivid Seats
SEAT
$67.7M
$214K ﹤0.01%
32,837
-2,255
-6% -$17.3K
HNDL icon
5778
Strategy Shares Nasdaq 7HANDL Index ETF
HNDL
$630M
$214K ﹤0.01%
9,360
-722
-7% -$16.3K
BDL icon
5779
Flanigan's Enterprises
BDL
$84.6M
$214K ﹤0.01%
4,762
+1
+0% +$34
CRBU icon
5780
Caribou Biosciences
CRBU
$174M
$214K ﹤0.01%
121,320
-123,792
-51% -$245K
GTEK icon
5781
Goldman Sachs Future Tech Leaders Equity ETF
GTEK
$240M
$213K ﹤0.01%
3,393
+1,643
+94% +$88.9K
LRGC icon
5782
AB US Large Cap Strategic Equities ETF
LRGC
$1.34B
$213K ﹤0.01%
2,548
CSB icon
5783
VictoryShares US Small Cap High Div Volatility Wtd ETF
CSB
$260M
$213K ﹤0.01%
3,240
-2,388
-42% -$153K
OPENZ
5784
Opendoor Technologies Inc Series Z Warrants
OPENZ
$4.12M
$212K ﹤0.01%
883,690
-57,960
-6% -$16.6K
BRZU icon
5785
Direxion Daily MSCI Brazil Bull 2X ETF
BRZU
$98.1M
$212K ﹤0.01%
2,378
-33
-1% -$3.47K
HCAT icon
5786
Health Catalyst
HCAT
$120M
$211K ﹤0.01%
106,127
-28,053
-21% -$40.5K
DH icon
5787
Definitive Healthcare
DH
$85.7M
$211K ﹤0.01%
254,149
-170,152
-40% -$156K
FTCI icon
5788
FTC Solar
FTCI
$42.1M
$211K ﹤0.01%
41,460
+25,675
+163% +$119K
MSTY icon
5789
YieldMax MSTR Option Income Strategy ETF
MSTY
$913M
$210K ﹤0.01%
17,172
-50
-0.3% -$1.07K
IMDX
5790
Insight Molecular Diagnostics
IMDX
$135M
$210K ﹤0.01%
35,515
-573
-2% -$2.83K
JTNY
5791
JPMorgan New York Tax Free Bond ETF
JTNY
$450M
$209K ﹤0.01%
+4,172
New +$210K
JDVI icon
5792
John Hancock Disciplined Value International Select ETF
JDVI
$793M
$209K ﹤0.01%
+5,427
New +$209K
ORMP icon
5793
Oramed Pharmaceuticals
ORMP
$209M
$209K ﹤0.01%
43,357
+29,305
+209% +$117K
FNUC
5794
Frontier Nuclear and Minerals Inc
FNUC
$54.2M
$207K ﹤0.01%
135,319
-341,385
-72% -$747K
MCGAU
5795
Yorkville Acquisition Corp Unit
MCGAU
$206K ﹤0.01%
20,000
AMTD
5796
AMTD IDEA Group
AMTD
$70.2M
$205K ﹤0.01%
212,867
PSBD icon
5797
Palmer Square Capital BDC
PSBD
$316M
$205K ﹤0.01%
19,639
-51,705
-72% -$552K
CLOX icon
5798
Panagram AAA CLO ETF
CLOX
$323M
$204K ﹤0.01%
7,945
+6,380
+408% +$163K
VCRB icon
5799
Vanguard Core Bond ETF
VCRB
$7.51B
$203K ﹤0.01%
2,634
-2,059
-44% -$159K
EEX
5800
DELISTED
Emerald Holding
EEX
$203K ﹤0.01%
40,327
-11,462
-22% -$55.7K

Similar funds

Morgan Stanley's Q2 2026 Portfolio in Review

As of Q2 2026, Morgan Stanley held 8,715 positions worth $1.89T, up 14% from $1.66T the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Morgan Stanley's Q2 2026 filing shows 423 new, 3,809 increased, 3,216 reduced and 305 closed positions. Its largest new stake was SpaceX: 13,532,773 shares worth $2.31B. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.96B.

By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Financials.

  • Morgan Stanley's largest Q2 2026 buy was SpaceX: 13,532,773 shares worth $2.31B.
  • Morgan Stanley added most to NVIDIA in Q2 2026, an estimated $2.77B increase.
  • Morgan Stanley's biggest Q2 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.96B.
  • Morgan Stanley fully exited Apellis Pharmaceuticals in Q2 2026, selling an estimated $404M.
  • Morgan Stanley's ten largest holdings make up 21% of its $1.89T portfolio in Q2 2026.
  • Morgan Stanley opened 423 new positions and closed 305 in Q2 2026.
  • Morgan Stanley's portfolio value rose 14% quarter-over-quarter to $1.89T.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.